Effects of the IK.ATP blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion
- 16 June 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 398 (2) , 273-284
- https://doi.org/10.1016/s0014-2999(00)00322-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Glibenclamide Does Not Prevent Action Potential Shortening Induced by Ischemia in Anesthetized Rabbits But Reduces Ischemia-induced ArrhythmiasJournal of Molecular and Cellular Cardiology, 1998
- Arrhythmias and Mortality After Myocardial Infarction in Diabetic Patients: Relationship to diabetes treatmentDiabetes Care, 1998
- KATPChannels Contribute to the Cardioprotection of Preconditioning Independent of Anaesthetics in Rabbit HeartsJournal of Molecular and Cellular Cardiology, 1997
- Sulfonylurea derivatives in cardiovascular research and in cardiovascular patientsCardiovascular Research, 1997
- Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitusThe American Journal of Cardiology, 1991
- A new method for analysing the geometry and timecourse of epicardial potential spreadingInternational Journal of Bio-Medical Computing, 1988
- Correlation between refractory periods and activation-recovery intervals from electrograms: effects of rate and adrenergic interventions.Circulation, 1985
- Intracellular Na+ activates a K+ channel in mammalian cardiac cellsNature, 1984
- Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations.Circulation, 1983
- Spread of activation in the left ventricular wall of the dog. IIAmerican Heart Journal, 1954